Percentage of patients, regardless of age, with a diagnosis of prostate cancer at high or very high risk of recurrence receiving external beam radiotherapy to the prostate who were prescribed androgen deprivation therapy in combination with external beam radiotherapy to the prostate
Patients who were prescribed androgen deprivation therapy in combination with external beam radiotherapy to the prostate
Denominator
1.15 Denominator
All patients, regardless of age, with a diagnosis of prostate cancer at high or very high risk of recurrence receiving external beam radiotherapy to the prostate
Exclusions
Exclusions
Denominator Exceptions: Documentation of medical reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate (eg, salvage therapy)
Documentation of patient reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate
Measure Record
Most Recent Endorsement Activity
Measure Retired and Endorsement Removed Cancer Project 2015-2016
Initial Endorsement
Last Updated
Removal Date
Point of Contact
Steward Organization
American Urological Association
Steward POC email
spope@auanet.org
Steward Organization Copyright
The AUAER and PCPI shall jointly hold all rights on the Measure, including copyright, in perpetuity, in all forms and media throughout the world, for the full term of copyright, including renewals. Notwithstanding the foregoing, the Measure will be available to the public free of charge for use in non-commercial endeavors without seeking any permissions (notices on the measures provide this permission, e.g., use by health care providers in connection with their practices is not a commercial use).
Public Comments